Humana Inc. (NYSE:HUM) Stock Holdings Lessened by Huntington National Bank

Huntington National Bank cut its stake in shares of Humana Inc. (NYSE:HUM) by 7.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,459 shares of the insurance provider’s stock after selling 627 shares during the quarter. Huntington National Bank’s holdings in Humana were worth $2,363,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. CarsonAllaria Wealth Management Ltd. boosted its position in shares of Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares during the period. Creative Financial Designs Inc. ADV boosted its holdings in shares of Humana by 244.0% in the third quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after buying an additional 61 shares during the period. Atwood & Palmer Inc. acquired a new position in shares of Humana in the third quarter worth about $29,000. Hantz Financial Services Inc. purchased a new position in shares of Humana in the second quarter worth approximately $35,000. Finally, Family Firm Inc. acquired a new stake in shares of Humana during the second quarter valued at approximately $37,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have weighed in on HUM. Leerink Partners cut shares of Humana from an “outperform” rating to a “market perform” rating and lowered their price objective for the stock from $400.00 to $250.00 in a research report on Wednesday, October 2nd. JPMorgan Chase & Co. lifted their price target on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. UBS Group reduced their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, October 4th. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $395.00 price target on shares of Humana in a research report on Tuesday, October 1st. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $315.86.

Humana Stock Down 2.6 %

HUM opened at $275.67 on Friday. The firm has a market cap of $33.19 billion, a P/E ratio of 24.42, a price-to-earnings-growth ratio of 2.29 and a beta of 0.52. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The business has a 50 day moving average price of $283.00 and a 200 day moving average price of $331.80. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $527.18.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Research analysts forecast that Humana Inc. will post 15.83 EPS for the current year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.28%. Humana’s payout ratio is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.